Natera Inc (NTRA)
123.54
-2.14 -1.70%
NASDAQ
Sep 23, 16:00
123.50
-0.04 -0.03%
After-Hours: 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 504.86M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -3.69 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -314.61M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 46.41% |
| Profit Margin (Quarterly) | -81.69% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 11.59B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 20.89 |
| PE Ratio | -- |
| Price to Book Value | 38.73 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 1.103 |
| Free Cash Flow (Quarterly) | -79.19M |
| Return on Equity | Upgrade |
View All NTRA News
News
-
WireHeadlineTime (ET)
-
Yahoo09/22 13:40
-
PR Newswire09/17 08:33
-
Yahoo09/13 11:09
-
MT Newswires09/13 08:05
-
Yahoo09/09 08:33
-
PR Newswire09/07 06:03
-
Yahoo08/31 08:30
-
Yahoo08/10 09:38
-
PR Newswire08/10 09:03
-
MT Newswires08/09 09:39
-
MT Newswires08/06 08:58
-
Yahoo08/05 20:55
-
MT Newswires08/05 17:29
-
MT Newswires08/05 16:45
-
PR Newswire08/05 16:05
-
MT Newswires08/04 15:57
-
PR Newswire08/04 09:03
-
PR Newswire07/29 09:03
-
Yahoo07/28 15:03
-
PR Newswire07/28 09:03
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/05/2021 | Earnings Results | Q3 2021 Earnings Results |
| 11/05/2021 16:30 EST | Earnings Calls | Q3 2021 Earnings Call |
| 08/05/2021 | Earnings Results | Q2 2021 Earnings Results |
| 08/05/2021 16:30 EST | Earnings Calls | Q2 2021 Earnings Call |
| 05/25/2021 14:30 EST | AGM | 2020 Annual General Meeting |
| 05/06/2021 | Earnings Results | Q1 2021 Earnings Results |
| 05/06/2021 16:30 EST | Earnings Calls | Q1 2021 Earnings Call |
| 02/25/2021 | Earnings Results | Q4 2020 Earnings Results |
| 02/25/2021 16:30 EST | Earnings Calls | Q4 2020 Earnings Call |
| 11/05/2020 | Earnings Results | Q3 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services include Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result.
- URL: https://www.natera.com
- Investor Relations URL: https://investor.natera.com
- HQ State/Province: Texas
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Nov. 05, 2021
- Last Earnings Release: Aug. 05, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 123.54 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| ASYMX | Alger Weatherbie Specialized Growth Y | 5.86% |
| GNOM | Global X Genomics & Biotechnology ETF | 4.42% |
| PTH | Invesco DWA Healthcare Momentum ETF | 3.81% |
| AOFCX | Alger Small Cap Focus C | 3.28% |
| WGFCX | Wells Fargo Growth C | 2.69% |
| BBH | VanEck Biotech ETF | 2.34% |
| LADQX | Lord Abbett Developing Growth R2 | 1.81% |
| ASG | Liberty All-Star Growth | 1.74% |
| ASPYX | Alger Spectra Y | 1.28% |
| FKBSX | Federated Hermes Kaufmann Small Cap B | 1.17% |
| XBI | SPDR® S&P Biotech ETF | 0.77% |
| SCHA | Schwab US Small-Cap ETF™ | 0.26% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NTRA Tweets Stocktwits
Advertisement
